This review summarizes the hallmark MRI features, lesion dynamics, and diagnostic protocols for myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), contrasting it with MS and AQP4+NMOSD, and covering emerging AI and advanced imaging applications.
MOGAD shows characteristic MRI findings including frequent T2-lesion resolution, rare asymptomatic radiological activity, and radiologic lag during acute attacks — patterns that differ meaningfully from the persistent lesions and subclinical activity seen in MS. A standardized MRI protocol for acute attacks is proposed.
This is a narrative review without a systematic search or meta-analysis; no original patient-level data are reported, so quantitative effect estimates are absent. Evidence underpinning specific recommendations is not graded explicitly.
Recognize that MOGAD lesions frequently resolve on T2 MRI and asymptomatic radiological activity is rare, making routine surveillance MRI less useful than in MS. Use the proposed standardized acute-attack MRI protocol and consider rebaselining MRI after symptom onset to avoid misdiagnosis.